Brett R Hagen Allovir, Inc. (ALVR) insider trading activity

ALVR Quotes by TradingView

Brett R Hagen is Chief Accounting Officer of Allovir, Inc.. Currently has a direct ownership of 68,506 shares of ALVR, which is worth approximately $39,048. The most recent transaction as insider was on Aug 17, 2023, when has been sold 1,653 shares (Common Stock) at a price of $2.5 per share, resulting in proceeds of $4,132. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.5K
4.83% 3M change
45.56% 12M change
Total Value Held $39,048

Brett R Hagen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2023
SELL
Open market or private sale
$4,132 $2.5 p/Share
1,653 Reduced 1.28%
127,175 Common Stock
Jul 20 2023
SELL
Open market or private sale
$1,145 $3.35 p/Share
342 Reduced 0.26%
128,828 Common Stock
Jul 19 2023
SELL
Open market or private sale
$1,217 $3.56 p/Share
342 Reduced 0.26%
129,170 Common Stock
Jun 09 2023
SELL
Open market or private sale
$28,453 $5.64 p/Share
5,045 Reduced 3.75%
129,512 Common Stock
Apr 20 2023
SELL
Open market or private sale
$1,266 $3.63 p/Share
349 Reduced 0.26%
134,557 Common Stock
Apr 19 2023
SELL
Open market or private sale
$1,291 $3.71 p/Share
348 Reduced 0.26%
134,906 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
61,250 Added 31.17%
135,254 Common Stock
Jan 20 2023
SELL
Open market or private sale
$1,737 $5.14 p/Share
338 Reduced 0.45%
74,004 Common Stock
Jan 19 2023
SELL
Open market or private sale
$7,909 $5.08 p/Share
1,557 Reduced 2.05%
74,342 Common Stock
Nov 11 2022
SELL
Open market or private sale
$147,329 $8.18 p/Share
18,011 Reduced 19.18%
75,899 Common Stock
Nov 10 2022
SELL
Open market or private sale
$47,912 $8.0 p/Share
5,989 Reduced 6.0%
93,910 Common Stock
Oct 24 2022
SELL
Open market or private sale
$16,260 $8.13 p/Share
2,000 Reduced 1.96%
99,899 Common Stock
Oct 21 2022
SELL
Open market or private sale
$95,772 $8.45 p/Share
11,334 Reduced 10.01%
101,899 Common Stock
Oct 19 2022
SELL
Open market or private sale
$3,229 $9.36 p/Share
345 Reduced 0.3%
113,233 Common Stock
Aug 16 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 14.97%
113,578 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
10,500 Added 10.09%
93,578 Common Stock
Apr 20 2022
SELL
Open market or private sale
$1,844 $6.68 p/Share
276 Reduced 0.34%
80,368 Common Stock
Jan 20 2022
SELL
Open market or private sale
$13,676 $8.75 p/Share
1,563 Reduced 2.41%
63,202 Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
17,442 Added 17.78%
80,644 Common Stock
Feb 22 2021
SELL
Open market or private sale
$34,512 $43.14 p/Share
800 Reduced 1.22%
64,765 Common Stock
Feb 18 2021
SELL
Open market or private sale
$29,544 $39.87 p/Share
741 Reduced 1.12%
65,565 Common Stock
Feb 17 2021
SELL
Open market or private sale
$93,542 $40.32 p/Share
2,320 Reduced 3.38%
66,306 Common Stock
Feb 16 2021
SELL
Open market or private sale
$128,832 $42.24 p/Share
3,050 Reduced 4.26%
68,626 Common Stock
Jan 19 2021
BUY
Grant, award, or other acquisition
-
17,500 Added 19.62%
71,676 Common Stock
BRH

Brett R Hagen

Chief Accounting Officer
Waltham, MA

Track Institutional and Insider Activities on ALVR

Follow Allovir, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALVR shares.

Notify only if

Insider Trading

Get notified when an Allovir, Inc. insider buys or sells ALVR shares.

Notify only if

News

Receive news related to Allovir, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALVR